Fluorescent bicyclic furo pyrimidine deoxynucleoside analogs as potent and selective inhibitors of VZV and potential future drugs for the treatment of chickenpox and shingles

Drugs of the Future

Volumn 25, Issue 11, 2000, Pages 1151-1161

  McGuigan, C ^a   Brancale, A ^a   Barucki, H ^a   Srinivasan, S ^a   Jones, G ^a   Pathirana, R ^a   Blewett, S ^a   Alvarez, R ^a   Yarnold, C J ^a   Carangio, A ^a   Velazquez S ^a   Andrei, G ^a   Snoeck, R ^a   De Clercq, E ^a   Balzarini, J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BICYCLO COMPOUND; NUCLEOSIDE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ANTIVIRAL ACTIVITY; CHICKENPOX; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG SOLUBILITY; HERPES ZOSTER; LIPOPHILICITY; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; VARICELLA ZOSTER VIRUS; VIRUS INHIBITION;

EID: 0034500752     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2000.025.11.858698     Document Type: Review

References (45)

1. Antiviral and antitumor activities of 5-substituted 2′-deoxyuridines
2. Biochemical aspects of the selective antiherpes activity of nucleoside analogs
3. (E)-5-(2-Bromovinyl)-2′-deoxyuridine. A potent and selective antiherpes agent
4. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus
5. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2′-deoxyuridines on mouse leukemia L1210 cell
6. Differential affinities of 5-(2-halogeno vinyl)-2′-deoxyuridines for deoxythymidine kinases of various origins
7. Inhibition of thymidylate synthetase by 5-alkynyl-2′-deoxyurioylates
8. Fluorinated pyrimidines as tight binding inhibitors of thymidylate synthetase
9. Design, synthesis and biological evaluation of novel nucleotide prodrugs as inhibitors of HIV replication
10. Mechanism of anti-HIV action of masked alaninyl d4TMP derivatives
11. Conversion of 2′,3′-dideoxyadenosine (ddA) and 2′,3′-didehydro-2′,3′-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus
12. Certain phosphoramidate derivatives of dideoxy uridine (ddU) are active against HIV and successfully by-pass thymidine kinase
13. Synthesis and evaluation of 5-halo 2′,3′-didehydro-2′,3′-dideoxy nucleosides and their blocked phosphoramidates as potential anti-HIV agents: An example of kinase bypass
14. Nucleic acid-related compounds. 40. Synthesis and biological activities of 5-alkynyluracil nucleosides
15. Nucleic acid-related compounds. 39. Efficient conversion of 5-iodo to 5-alkynyl and derived 5-substituted uracil bases and nucleosides
16. Nucleic acid-related compounds. 31. Smooth and efficient palladium copper catalyzed coupling of terminal alkynes with 5-iodouracil nucleosides
17. Palladium-catalyzed coupling of terminal alkynes with 5-(trifluoromethanesulfonyloxy)pyrimidine nucleosides
18. Nucleic acid-related compounds. 59. Solvent, not palladium oxidation state, is the primary determinant for successful coupling of terminal alkynes with iodo nucleosides
19. Incorporation of 5-substituted uracil derivatives into nucleic acids. III. Synthesis of 5-substituted uracils derived from 5-acetyluracil
20. Synthesis and biological evaluation of 5-(1-alkoxy-2-haloethyl)-2′-deoxyuridines and related uracil analogs
21. Steric fixation of bromovinyluracil - Synthesis of furo [2,3-d]pyrimidine nucleosides
22. Synthesis of 5-(1-azidovinyl) and 5-[2-(1-azirinyl)] analogs of 2′-deoxyuridine
23. Synthesis of dodecadeoxyribonucleotides containing a pyrrolo[2,3-d]pyrimidine nucleoside and their base-pairing ability
24. Oxidative addition of unsaturated acid-esters to 1,3-dimethyluracil and pyrimidine nucleosides
25. Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base
26. A novel selective broad-spectrum anti-DNA virus agent
27. Multiple dose netivudine, a potent anti-varicella zoster virus agent, in healthy elderly volunteers and patients with shingles
28. 5-Alkynyl pyrimidine nucleosides as potent selective inhibitors of varicella-zoster virus
29. New fluorinating reagents. Dialkylaminosulfur fluorides
30. A stereospecific route to aziridinomitosanes: The synthesis of novel mitomycin congeners
31. 5′
32. Design, synthesis and evaluation of new antiviral nucleosides
33. Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): The effect of a terminal halogen substitution in the side chain
34. Preparation of alkynes and dialkynes by reaction of monohalo- and dihaloalkanes with lithium acetylenide-ethylenediamine complex
35. Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): The effect of terminal unsaturation in the side-chain
36. Extremely potent and selective inhibition of varicella-zoster virus (VZV) by bicyclic furo pyrimidine nucleosides bearing an aryl side-chain
37. Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus
38. Synthesis and anti-VZV activity of some novel bicyclic nucleoside inhibitors: Effects of enhanced water solubility
39. G/C-modified oligodeoxynucleotides with selective complementarity: Synthesis and hybridization properties
40. Anti-varicella-zoster virus (VZV) fluorescent bicyclic nucleosides: Replacement of furo by pyrro base reduces antiviral potency
41. In vitro anti-herpes action of a novel antiviral agent, brovadir (BV-araU)
42. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus, type III/lymphadenopathy-associated virus (HTLV III/LAV) by 2′,3′-didoxynucleosides
43. Novel mouse models for the investigation of experimental drugs with activity against human varicella-zoster virus